HBP Helix BioPharma Corp

TORONTO, May 26, 2016 /CNW/ - Dr. Sven Rohmann, CEO and President, Helix BioPharma Corp. (HBP), joined Richard Rohan, VP, Corporate Sales, TMX Equity Transfer & Trust Company, to open the market to celebrate 20 years listed on Toronto Stock Exchange. Helix BioPharma Corp. is a biopharmaceutical company specializing in the development and commercialization of medicines in the areas of cancer prevention and treatment. Helix BioPharma Corp. commenced trading on Toronto Stock Exchange on June 3, 1996.

SOURCE TMX Group Limited